EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Tumor localization strategies of multicancer early detection tests: a quantitative assessment

Christopher Tyson, Kevin H Li, Xiting Cao, James M O'Brien, Elliot K Fishman iD, Elizabeth K O'Donnell, Carlos Duran iD, Vijay Parthasarathy, Seema P Rego, Omair A Choudhry iD, Tomasz M Beer iD

JNCI Cancer Spectrum · 03.03.2025 · 9 (2)

DOI: 10.1093/jncics/pkaf011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI Cancer Spectrum, online erschienen am 24.01.2025. Verfasst von Christopher Tyson und 10 weiteren Autor:innen. Beteiligte Einrichtung: Exact Sciences Corporation, Madison, WI 53719, United States. Hauptthemen laut MEDLINE: Early Detection of Cancer, Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Multicancer early detection tests may expand cancer screening. Characterizing diagnostic resolution approaches following positive multicancer early detection tests is critical. Two trials employed distinct resolution approaches: a molecular signal to predict tissue of origin and an imaging-based diagnostic strategy. This modeling study characterizes diagnostic journeys and impact in a hypothetical population of average-risk multicancer early detection–eligible patients.

Methods

A mathematical expression for diagnostic burden was derived using positive predictive value (PPV), molecular tissue of origin localization accuracy, and numbers of procedures associated with each diagnostic outcome. Imaging-based and molecular tissue of origin–informed strategies were compared. Excess lifetime cancer risk due to futile radiation exposure was estimated using organ-specific diagnostic imaging radiation doses.

Results

Across all PPVs and localization performances, a molecular tissue of origin strategy resulted in a higher diagnostic burden (mean = 3.6 [0.445] procedures vs mean = 2.6 [0.100] procedures) for the imaging strategy. Estimated diagnostic burden was higher for molecular tissue of origin in 95.5% of all PPV and tissue of origin accuracy combinations; at least 79% PPV and 90% accuracy would be required for a molecular tissue of origin–informed strategy to be less burdensome than imaging. The maximum rate of excess cancer incidence from radiation exposure for multicancer early detection false-positive results (individuals aged 50-84 years) was 64.6 of 100 000 (annual testing, 99% specificity), 48.5 of 100 000 (biennial testing, 98.5% specificity), and 64.6 of 100 000 (biennial testing, 98% specificity).

Conclusions

An imaging-based diagnostic strategy is more efficient than a molecular tissue of origin–informed approach across almost all PPV and tissue of origin accuracy combinations. The use of an imaging-based approach for cancer localization can be efficient and low-risk compared with a molecular-informed approach.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Early Detection of CancerNeoplasmsHumansPredictive Value of TestsModels, TheoreticalRadiation Dosage

Autor:innen und Institutionen

  • Exact Sciences Corporation, Madison, WI 53719, United States.
  • Visionquest Development Partners, Atlanta, GA 30240, United States.
  • Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21231, United States.
  • Dana-Farber Cancer Institute, Harvard University, Boston, MA 02215, United States.

ORCID-Profile: Elliot K Fishman, Carlos Duran, Omair A Choudhry, Tomasz M Beer

Zitieren

APA

Tyson, C., Li, K. H., Cao, X., O'Brien, J. M., Fishman, E. K., O'Donnell, E. K., Duran, C., Parthasarathy, V., Rego, S. P., Choudhry, O. A., & Beer, T. M. (2025). Tumor localization strategies of multicancer early detection tests: a quantitative assessment. JNCI Cancer Spectrum, 9(2). https://doi.org/10.1093/jncics/pkaf011

Vancouver

Tyson C, Li KH, Cao X, O'Brien JM, Fishman EK, O'Donnell EK, et al. Tumor localization strategies of multicancer early detection tests: a quantitative assessment. JNCI Cancer Spectrum. 2025;9(2). doi:10.1093/jncics/pkaf011

BibTeX
@article{Tyson2025,
  author = {Tyson, Christopher and Li, Kevin H and Cao, Xiting and O'Brien, James M and Fishman, Elliot K and O'Donnell, Elizabeth K and Duran, Carlos and Parthasarathy, Vijay and Rego, Seema P and Choudhry, Omair A and Beer, Tomasz M},
  title = {Tumor localization strategies of multicancer early detection tests: a quantitative assessment},
  journal = {JNCI Cancer Spectrum},
  year = {2025},
  volume = {9},
  number = {2},
  doi = {10.1093/jncics/pkaf011}
}
Kostenlos starten →